Endothelial Function in Women with and without a History of Glucose Intolerance in Pregnancy

by Shireen Brewster, John Floras, Bernard Zinman, Ravi Retnakaran
Published 2013-01-01

Neighborhood walkability and risk of gestational diabetes

by Sadia Mehmood, Mathew Sermer, Bernard Zinman, Simone Kew
Published 2020-04-01

Impact of Maternal Physical Activity and Infant Feeding Practices on Infant Weight Gain and Adiposity

by Lisa Chu, Ravi Retnakaran, Bernard Zinman, Anthony J. G. Hanley, Jill K. Hamilton
Published 2012-01-01

Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes

by Sadia Mehmood, Chang Ye, Philip W. Connelly, Anthony J. Hanley, Bernard Zinman, Ravi Retnakaran
Published 2018-10-01

Predicting and understanding the response to short-term intensive insulin therapy in people with early type 2 diabetes

by Yury O. Nunez Lopez, Ravi Retnakaran, Bernard Zinman, Richard E. Pratley, Attila A. Seyhan
Published 2019-02-01

Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA‐REG OUTCOME

by Pierpaolo Pellicori, Anne Pernille Ofstad, David Fitchett, Cordula Zeller, Christoph Wanner, Jyothis George, Bernard Zinman, Martina Brueckmann, JoAnn Lindenfeld
Published 2020-12-01

Clusters of fatty acids in the serum triacylglyceride fraction associate with the disorders of type 2 diabetes

by Luke W. Johnston, Zhen Liu, Ravi Retnakaran, Bernard Zinman, Adria Giacca, Stewart B. Harris, Richard P. Bazinet, Anthony J. Hanley
Published 2018-09-01

Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes m...

by Geert Jan Biessels, Jolien Janssen, Esther van den Berg, Bernard Zinman, Mark A. Espeland, Michaela Mattheus, Odd Erik Johansen, on behalf of the CAROLINA® investigators
Published 2018-01-01

Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes*[S]

by Philip W. Connelly, Bernard Zinman, Graham F. Maguire, Mary Mamakeesick, Stewart B. Harris, Robert A. Hegele, Ravi Retnakaran, Anthony J.G. Hanley
Published 2009-06-01

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

by João Pedro Ferreira, Subodh Verma, David Fitchett, Anne Pernille Ofstad, Sabine Lauer, Isabella Zwiener, Jyothis George, Christoph Wanner, Bernard Zinman, Silvio E. Inzucchi
Published 2020-11-01

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14

by Richard E. Pratley, Mansoor Husain, Ildiko Lingvay, Thomas R. Pieber, Thomas Mark, Hans A. Saevereid, Daniel Vega Møller, Bernard Zinman, the DEVOTE Study Group
Published 2019-11-01

ACE-I and ARBs in early diabetic nephropathy

by Michael Mauer, Bernard Zinman, Robert Gardiner, Keith N Drummond, Samy Suissa, Sandra M Donnelly, Trudy D Strand, Michael S Kramer, Ronald Klein, Alan R Sinaiko
Published 2002-12-01

Time to cardiovascular benefits of empagliflozin: a post hoc observation from the EMPA‐REG OUTCOME trial

by Subodh Verma, Lawrence A. Leiter, Bernard Zinman, Abhinav Sharma, Michaela Mattheus, David Fitchett, Jyothis George, Anne Pernille Ofstad, Mikhail N. Kosiborod, Christoph Wanner, Silvio E. Inzucchi
Published 2021-08-01

Traditional foods and 25(OH)D concentrations in a subarctic First Nations community

by Sudaba Mansuri, Alaa Badawi, Sheena Kayaniyil, David E. Cole, Stewart B. Harris, Mary Mamakeesick, Thomas Wolever, Joel Gittelsohn, Jonathon L. Maguire, Philip W. Connelly, Bernard Zinman, Anthony J. Hanley
Published 2016-09-01

APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians

by Piya Lahiry, Henian Cao, Matthew R. Ban, Rebecca L. Pollex, Mary Mamakeesick, Bernard Zinman, Stewart B. Harris, Anthony J.G. Hanley, Murray W. Huff, Philip W. Connelly, Robert A. Hegele
Published 2010-04-01

Examining the relationship between maternal body size, gestational glucose tolerance status, mode of delivery and ethnicity on human milk microbiota at three months post-partum

by Lauren LeMay-Nedjelski, James Butcher, Sylvia H. Ley, Michelle R. Asbury, Anthony J. Hanley, Alex Kiss, Sharon Unger, Julia K. Copeland, Pauline W. Wang, Bernard Zinman, Alain Stintzi, Deborah L. O’Connor
Published 2020-07-01

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes.

by Bruce A Perkins, David Z I Cherney, Nima Soleymanlou, Justin A Lee, Helen Partridge, Holly Tschirhart, Bernard Zinman, Roger Mazze, Nora Fagan, Stefan Kaspers, Hans-Juergen Woerle, Uli C Broedl, Odd Erik Johansen
Published 2015-01-01

Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis

by Vinay Garg, Subodh Verma, Kim A. Connelly, Andrew T. Yan, Aditya Sikand, Ankit Garg, Paul Dorian, Fei Zuo, Lawrence A. Leiter, Bernard Zinman, Peter Jüni, Atul Verma, Hwee Teoh, Adrian Quan, C. David Mazer, Andrew C.T. Ha
Published 2020-09-01

Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placeb...

by Julio Rosenstock, Vlado Perkovic, John H. Alexander, Mark E. Cooper, Nikolaus Marx, Michael J. Pencina, Robert D. Toto, Christoph Wanner, Bernard Zinman, David Baanstra, Egon Pfarr, Michaela Mattheus, Uli C. Broedl, Hans-Juergen Woerle, Jyothis T. George, Maximilian von Eynatten, Darren K. McGuire, CARMELINA® investigators
Published 2018-03-01